Ruma Care

Ruma Care

We help clinics get patients on biologics faster

Winter 2026ActiveHealthcareHealthcareAISan Francisco, CA, USA
Ruma Care automates prior authorizations - we’re starting with clinics that administer the most expensive specialty medications. Biologics are expensive medications that cost $80-$150K+ per year per patient, and often need to be administered in specific settings called infusion clinics. Medical providers buy these drugs up front to secure pricing deals and safer inventory - they are reimbursed for the cost of the medications through the patients’ insurance. Because they’re so expensive, these specialty medications are denied by insurers at a rate of 37% each year. When they are denied, providers don’t get reimbursed for the medication and are left covering the costs. Ruma Care solves this so clinics get paid, patients get treated faster, and care teams spend less time fighting insurance. We do this in three ways: 1. For each medication, diagnosis, and insurance combination, Ruma extracts the submission criteria required to get the drug approved by insurers. 2. We pull out the correct forms, then automate the form-filling for prior authorizations. 3. Lastly, we enroll patients in copay assistance programs, all in one workflow and platform. We turn a process that traditionally spans 70+ online portals, disparate paper forms, and manual phone calling into a single, streamlined platform. As we process prior authorizations, our models learn from denial patterns to understand exactly what insurers need to see to get a prior authorization approved.

Verdict

High Signal
Market Opportunity
Biologics are $80-150K+/year per patient medications with a $60B medication access problem cited by founders. Prior auth automation for specialty medications in infusion clinics is a clear B2B healthcare ICP with direct monetization tied to denial reduction (clinics lose money on denied buy-and-bill reimbursements). 37% annual denial rate on these high-cost drugs creates urgent, recurring pain with measurable ROI.
High Signal
Founder Signal
Christina Huang (CTO) has strong technical depth: AI/ML at Apple (2019-2022, MIND team), full-stack at Medallion leading UnitedHealthcare integrations (2022-2024), SE at Sigma (2024-2025), Yale EECS. Meng Fei Shen (CEO) led Uber One to 13M+ members and worked on AI integrations at Walmart Data Ventures — then literally quit to work as a medical assistant at an infusion clinic to understand the problem firsthand. This founder-market fit through direct domain immersion is exceptional and rare. Both are Yale grads but their work experience is the real signal.
Medium Signal
Competition
CoverMyMeds is explicitly named in the FAQ as a competitor, indicating the broader ePA space is contested. Larger incumbents like Surescripts, Availity, and various EHR-native PA tools exist. Ruma's differentiation is specialization in biologics/infusion clinics specifically (versus general ePA), combined with copay enrollment and buy-and-bill reimbursement support in one workflow, plus the learning layer from denial patterns. Niche focus is a real moat but big players could expand into this vertical.
Medium Signal
Product
Live product with a named customer testimonial (Janeen Thompson, San Mateo Rheumatology) and specific metrics claimed in founder posts: 55% reduction in denial rates and 20x reduction in staff time per prior auth. Product is live across clinics in California and Nevada per LinkedIn post. However, FAQ answers appear to be placeholder Framer template text, no pricing page, and no revenue figures disclosed.
OverallA Tier

Ruma Care has one of the strongest founder-market fit stories in the batch — the CEO literally became a medical assistant to understand the problem, and the CTO has direct prior experience integrating with UnitedHealthcare at Medallion. The problem is real, expensive, and urgent: infusion clinics eat losses on denied biologics reimbursements. They're live with paying customers and have specific, credible metrics (55% denial reduction, 20x time savings). The main risks are the crowded ePA space with incumbents like CoverMyMeds and whether they can scale beyond a handful of California/Nevada clinics before larger players target this niche. FAQ placeholders still containing Framer boilerplate is a minor execution flag.

Active Founders

Christina Huang
Christina Huang
Founder

Co-founder & CTO @ Ruma Care (W26). Previously, led integrations with United Healthcare at Medallion, and built robots, multimodal models, and voice assisted experiences at Apple.

Meng Fei Shen
Meng Fei Shen
Founder

Co-founder & CEO @ Ruma Care (W26). Previously, led Uber One global to 13M+ members and AI integrations for 100K+ suppliers at Walmart Data Ventures. Runs a 120+ person music collective in SF @juicytrees

Ruma Care
Ruma Care
TierA Tier
BatchWinter 2026
Team Size2
StatusActive
LocationSan Francisco, CA, USA